Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 271

    1.
    2.

    High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.

    Borg H, Gottsäter A, Landin-Olsson M, Fernlund P, Sundkvist G.

    J Clin Endocrinol Metab. 2001 Jul;86(7):3032-8.PMID: 11443164 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

    Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK.

    Diabetes Care. 2000 Jun;23(6):838-44.PMID: 10841006 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

    Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R.

    Lancet. 1997 Nov 1;350(9087):1288-93. Erratum in: Lancet 1998 Jan 31;351(9099):376. PMID: 9357409 [PubMed - indexed for MEDLINE]Related articles

    5.

    Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

    Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Rottiers R; Belgian Diabetes Registry.

    Diabetes Care. 2000 Aug;23(8):1072-8.PMID: 10937500 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.

    Törn C, Landin-Olsson M, Ostman J, Scherstén B, Arnqvist H, Blohmé G, Björk E, Bolinder J, Eriksson J, Littorin B, Nyström L, Sundkvist G, Lernmark A.

    Diabetes Metab Res Rev. 2000 Nov-Dec;16(6):442-47.PMID: 11114103 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.

    Törn C, Landin-Olsson M, Lernmark A, Scherstén B, Ostman J, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Eriksson J, Littorin B, Nyström L, Sundkvist G.

    Autoimmunity. 2001;33(2):115-20.PMID: 11264790 [PubMed - indexed for MEDLINE]Related articles

    8.

    Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

    Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G.

    Diabetes Care. 1993 Jun;16(6):902-10.PMID: 8325204 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.

    Lindholm E, Hallengren B, Agardh CD.

    Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):158-64.PMID: 15037992 [PubMed - indexed for MEDLINE]Related articles

    11.

    Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.

    Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA.

    Diabetologia. 1998 Aug;41(8):891-7.PMID: 9726590 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies]

    Yang L, Zhou ZG, Huang G, Yan X.

    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Jun;29(3):309-14. Chinese. PMID: 16136967 [PubMed - indexed for MEDLINE]Related articles

    13.

    Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.

    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.

    J Autoimmun. 1998 Dec;11(6):643-50.PMID: 9878086 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Detection of antibodies against pancreatic islet cells in clinical practice]

    Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.

    Orv Hetil. 1999 Nov 28;140(48):2695-701. Hungarian. PMID: 10645715 [PubMed - indexed for MEDLINE]Related articles

    15.

    A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.

    Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G.

    Diabet Med. 2004 May;21(5):456-9.PMID: 15089790 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.

    Singh AK, Bhatia E, Dabadghao P, Bhatia V, Gellert SA, Colman PG.

    Diabet Med. 2000 Apr;17(4):275-80.PMID: 10821293 [PubMed - indexed for MEDLINE]Related articles

    17.

    GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.

    Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI.

    Diabetes Care. 1995 Dec;18(12):1557-65.PMID: 8722051 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.

    Sabbah E, Savola K, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Akerblom HK, Knip M.

    J Clin Endocrinol Metab. 1999 May;84(5):1534-9.PMID: 10323375 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prognostic factors for the course of beta cell function in autoimmune diabetes.

    Törn C, Landin-Olsson M, Lernmark A, Palmer JP, Arnqvist HJ, Blohmé G, Lithner F, Littorin B, Nyström L, Scherstén B, Sundkvist G, Wibell L, Ostman J.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4619-23.PMID: 11134117 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.

    Ostman J, Landin-Olsson M, Törn C, Palmer J, Lernmark A, Arnqvist H, Björk E, Bolinder J, Blohmé G, Eriksson J, Littorin B, Nyström L, Scherstén B, Sundkvist G, Wibell L.

    Diabet Med. 2000 Apr;17(4):269-74.PMID: 10821292 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data